113 related articles for article (PubMed ID: 7903177)
1. The relationship between LeY antigen and the therapeutic efficacy of interferon in chronic hepatitis C.
Sata M; Nakano H; Hino T; Kosedo T; Adachi M; Tanikawa K
Arch Virol Suppl; 1993; 8():265-9. PubMed ID: 7903177
[TBL] [Abstract][Full Text] [Related]
2. T-lymphocyte subpopulations as factors predicting clinical response to interferon in hepatitis C virus-related chronic active hepatitis.
Guadagnino V; Caroleo B; Izzi A; De Rosa G; D'Amelio R
Infection; 1995; 23(3):189-90. PubMed ID: 7499011
[No Abstract] [Full Text] [Related]
3. Peripheral blood lymphocyte subsets in patients with chronic hepatitis C--effects of interferon treatment.
Wejstål R; Norkrans G; Lenkei R; Weiland O; Schvarcz R; Frydén A
Liver; 1992 Aug; 12(4 Pt 1):161-7. PubMed ID: 1406078
[TBL] [Abstract][Full Text] [Related]
4. In-situ immunophenotyping study of hepatic-infiltrating cytotoxic cells in chronic active hepatitis C.
Fiore G; Angarano I; Caccetta L; Serrone M; Jirillo E; Schiraldi O; Antonaci S
Eur J Gastroenterol Hepatol; 1997 May; 9(5):491-6. PubMed ID: 9187883
[TBL] [Abstract][Full Text] [Related]
5. T cell receptor excision circles (TRECs), CD4+, CD8+, and their CD45RO+, and CD45RA+, subpopulations in hepatitis C virus (HCV)-HIV-co-infected patients during treatment with interferon alpha plus ribavirin: analysis in a population on effective antiretroviral therapy.
Arizcorreta A; Márquez M; Fernández-Gutiérrez C; Guzmán EP; Brun F; Rodríguez-Iglesias M; Girón-González JA
Clin Exp Immunol; 2006 Nov; 146(2):270-7. PubMed ID: 17034579
[TBL] [Abstract][Full Text] [Related]
6. Antigen-specific activation and proliferation of CD4+ and CD8+ T lymphocytes from brucellosis patients.
Moreno-Lafont MC; López-Santiago R; Zumarán-Cuéllar E; Paredes-Cervantes V; López-Merino A; Estrada-Aguilera A; Santos-Argumedo L
Trans R Soc Trop Med Hyg; 2002; 96(3):340-7. PubMed ID: 12174793
[TBL] [Abstract][Full Text] [Related]
7. Immune responses during acute and chronic infection with hepatitis C virus.
Ishii S; Koziel MJ
Clin Immunol; 2008 Aug; 128(2):133-47. PubMed ID: 18514579
[TBL] [Abstract][Full Text] [Related]
8. Mapping of immunodominant CD4+ T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection.
Hoffmann RM; Diepolder HM; Zachoval R; Zwiebel FM; Jung MC; Scholz S; Nitschko H; Riethmüller G; Pape GR
Hepatology; 1995 Mar; 21(3):632-8. PubMed ID: 7875660
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte subsets and beta 2-microglobulin expression in chronic hepatitis C/non-A, non-B. Effects of interferon-alpha treatment.
Wejstål R; Norkrans G; Weiland O; Schvarcz R; Fuchs D; Wachter H; Fryden A; Glaumann H
Clin Exp Immunol; 1992 Mar; 87(3):340-5. PubMed ID: 1544220
[TBL] [Abstract][Full Text] [Related]
10. Expression of a novel activation antigen on intrahepatic CD8+ T lymphocytes in viral chronic active hepatitis.
García-Monzón C; Moreno-Otero R; Pajares JM; García-Sánchez A; López-Botet M; de Landázuri MO; Sánchez-Madrid F
Gastroenterology; 1990 Apr; 98(4):1029-35. PubMed ID: 2138103
[TBL] [Abstract][Full Text] [Related]
11. Intrahepatic mononuclear cell populations and MHC antigen expression in patients with chronic hepatitis C [correction of B]: effect of interferon-alpha.
Van Thiel DH; Zhang X; Baddour N; Wright HI; Friedlander L; Gavaler JS
Dig Dis Sci; 1994 May; 39(5):970-6. PubMed ID: 8174438
[TBL] [Abstract][Full Text] [Related]
12. Interferon-gamma production specific for hepatitis B virus antigen by intrahepatic T lymphocytes in patients with acute and chronic hepatitis B.
Kakumu S; Ishikawa T; Wakita T; Yoshioka K; Takayanagi M; Tahara H; Kusakabe A
Am J Gastroenterol; 1994 Jan; 89(1):92-6. PubMed ID: 8273806
[TBL] [Abstract][Full Text] [Related]
13. Oligoclonal CD8+ T-cell expansion in patients with chronic hepatitis C is associated with liver pathology and poor response to interferon-alpha therapy.
Manfras BJ; Weidenbach H; Beckh KH; Kern P; Möller P; Adler G; Mertens T; Boehm BO
J Clin Immunol; 2004 May; 24(3):258-71. PubMed ID: 15114056
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of an analysis of lymphocyte subsets in predicting the clinical response to alpha-interferon therapy in thalassaemia patients with chronic infection by hepatitis C virus: a pilot study.
Russo-Mancuso G; Di Gregorio F; Passero E; Sciotto A; Mazzarino MC; Malaponte G; Schilirò G
Br J Haematol; 1995 Feb; 89(2):291-8. PubMed ID: 7873379
[TBL] [Abstract][Full Text] [Related]
15. Intrahepatic lymphocyte subpopulations and HLA class I antigen expression by hepatocytes in chronic hepatitis C.
Onji M; Kikuchi T; Kumon I; Masumoto T; Nadano S; Kajino K; Horiike N; Ohta Y
Hepatogastroenterology; 1992 Aug; 39(4):340-3. PubMed ID: 1385287
[TBL] [Abstract][Full Text] [Related]
16. Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.
Quiroga JA; Llorente S; Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Carreño V
J Med Virol; 2006 Sep; 78(9):1190-7. PubMed ID: 16847959
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C.
Cramp ME; Rossol S; Chokshi S; Carucci P; Williams R; Naoumov NV
Gastroenterology; 2000 Feb; 118(2):346-55. PubMed ID: 10648463
[TBL] [Abstract][Full Text] [Related]
18. [Influence of interferon-alpha therapy on the count and function of T lymphocytes in children with chronic hepatitis C].
Woźniakowska-Gesicka T; Wiśniewska-Ligier M; Kupś J; Borowska-Rybus B; Sułat-Syncerek D; Grzegorczyk W
Pol Merkur Lekarski; 2001 Oct; 11(64):344-7. PubMed ID: 11770316
[TBL] [Abstract][Full Text] [Related]
19. Mouse hepatitis viral infection induces an extrathymic differentiation of the specific intrahepatic alpha beta-TCRintermediate LFA-1high T-cell population.
Lamontagne L; Massicotte E; Page C
Immunology; 1997 Mar; 90(3):402-11. PubMed ID: 9155648
[TBL] [Abstract][Full Text] [Related]
20. Fate and function of hepatitis-C-virus-specific T-cells during peginterferon-alpha2b therapy for acute hepatitis C.
Wiegand J; Cornberg M; Aslan N; Schlaphoff V; Sarrazin C; Kubitschke A; Buggisch P; Ciner A; Jaeckel E; Manns MP; Wedemeyer H
Antivir Ther; 2007; 12(3):303-16. PubMed ID: 17591020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
